Cargando…
Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma (MM) is an incurable hematological malignancy characterized by an increase in abnormal plasma cells. Disease progression, drug resistance, and immunosuppression in MM are associated with immune-related molecules, such as immune checkpoint and co-stimulatory molecules...
Autores principales: | Ishibashi, Mariko, Morita, Rimpei, Tamura, Hideto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828503/ https://www.ncbi.nlm.nih.gov/pubmed/33451089 http://dx.doi.org/10.3390/cancers13020279 |
Ejemplares similares
-
Immunotherapy for Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2019) -
PD-L1–PD-1 Pathway in the Pathophysiology of Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2020) -
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
por: Fouquet, Gregory, et al.
Publicado: (2018) -
Marine Morbilliviruses: Diversity and Interaction with Signaling Lymphocyte Activation Molecules
por: Ohishi, Kazue, et al.
Publicado: (2019)